Lactobacillus salivarius PS11603

Lactobacillus salivarius PS11603 (also known as Ligilactobacillus salivarius subsp. infantis PS11603) is a probiotic bacterial strain developed by Probiotical S.p.A. It is primarily investigated for its role in establishing a healthy gut microbiota in preterm infants, particularly those born between 28 and 30 weeks of gestation. In clinical studies, PS11603 has been administered in combination with Bifidobacterium longum PS10402 to enhance the early colonization of beneficial Lactobacilli and Bifidobacteria, which are often deficient in the neonatal intensive care environment. The strain functions as a live biotherapeutic, potentially improving digestive health and immune system maturation by modulating the intestinal microbial environment.

Other names

Ligilactobacillus salivarius subsp. infantis PS11603Ligilactobacillus salivarius PS11603L. salivarius PS11603